Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by SouthernTierTomon Feb 01, 2021 4:44pm
124 Views
Post# 32439837

RE:Heavyweight Hire -

RE:Heavyweight Hire - Let's sea ~~~~~~~~~~~~~~~~~......

SAMI
DIMI
101 more payments from Baxter for letting them "hang with us"
FDA approved EAA
PMX Covid trial
PMX phase 3B FDA trial with 2:1 ratio in favor of PMX therapy
Euphas phase 2 resutls
Euphas 2 registry
Insider ownership and willingness to HOLD and accumulate
Attractive entry point for options and potential additional insider purchases
Opportunity to have your name beside game-changing critical care medical discovery
Company car...heard they are looking at new Ford Focusses for the team
Legendary soft cookies at all company events with dinners at the Canadiana afterwards avec extra coleslaw besides your roti de bouef on a Francais stick.

Who knows...maybe he was duped into signing with a "small start-up Canadien drug-maker"

I'm just glad he has arrived to bring the ole girl into Whitefish Bay....any longer at sea and we end up having Canadien great Edmond Fitzgerald writing a song about us....you don't want that!  The Spectralotor bell chimed, it rang 135 times for each invester on the good ship in "per protocol patient peril"

C'mon John...let's show these canucks what good ole fashioned Yank know how can do!



<< Previous
Bullboard Posts
Next >>